Mycoplasma pneumoniae from the respiratory tract and beyond

KB Waites, L Xiao, Y Liu, MF Balish… - Clinical microbiology …, 2017 - Am Soc Microbiol
Mycoplasma pneumoniae is an important cause of respiratory tract infections in children as
well as adults that can range in severity from mild to life-threatening. Over the past several …

[HTML][HTML] Rational stepwise approach for Mycoplasma pneumoniae pneumonia in children

TA Tsai, CK Tsai, KC Kuo, HR Yu - Journal of Microbiology, Immunology …, 2021 - Elsevier
Mycoplasma pneumoniae is a common pathogen that causes community-acquired
pneumonia. In the past, M. pneumoniae was sensitive to macrolide antibiotics, and M …

Community-acquired pneumonia in children: updated perspectives on its etiology, diagnosis, and treatment

KW Yun - Clinical and Experimental Pediatrics, 2023 - pmc.ncbi.nlm.nih.gov
Pneumonia is a common pediatric infectious disease that is familiar to pediatricians and a
major cause of hospitalization worldwide. Recent well-designed epidemiologic studies in …

CRISPR/Cas9-based point-of-care lateral flow biosensor with improved performance for rapid and robust detection of Mycoplasma pneumonia

R Zhu, H Jiang, C Li, Y Li, M Peng, J Wang, Q Wu… - Analytica Chimica …, 2023 - Elsevier
Screening of acute respiratory infections causes serious challenges in urgent point-of-care
scenarios where conventional methods are impractical and alternative techniques suffer …

Behandlung von erwachsenen Patienten mit ambulant erworbener Pneumonie–Update 2021

S Ewig, M Kolditz, M Pletz, A Altiner, W Albrich… - …, 2021 - thieme-connect.com
Die vorliegende Leitlinie umfasst ein aktualisiertes Konzept der Behandlung und Prävention
von erwachsenen Patienten mit ambulant erworbener Pneumonie und löst die bisherige …

The clinical characteristics and risk factors for necrotizing pneumonia caused by Mycoplasma pneumoniae in children

B Zheng, J Zhao, L Cao - BMC infectious diseases, 2020 - Springer
Background The incidence of necrotizing pneumonia (NP) caused by Mycoplasma
pneumoniae (MP) is increasing. We analyzed the clinical characteristics and the risk factors …

[HTML][HTML] Altered chemokine profile in Refractory Mycoplasma pneumoniae pneumonia infected children

YC Lee, CH Chang, WJ Lee, TY Liu, CM Tsai… - Journal of Microbiology …, 2021 - Elsevier
Background Mycoplasma pneumoniae is one of the major pathogens causing community-
acquired pneumonia in children. Although usually self-limited, Mycoplasma pneumoniae …

The molecular characteristics, diagnosis, and treatment of macrolide-resistant Mycoplasma pneumoniae in children

M Leng, J Yang, J Zhou - Frontiers in Pediatrics, 2023 - frontiersin.org
The purpose of this study is to review the molecular characteristics, the diagnosis, and
treatment of the widespread infection of macrolide-resistant Mycoplasma pneumoniae (M …

Diagnosis of Mycoplasma pneumoniae Pneumonia with Measurement of Specific Antibody-Secreting Cells

PM Meyer Sauteur, M Seiler, J Trück… - American journal of …, 2019 - atsjournals.org
Methods Pediatric patients with CAP (n= 152) and control subjects (n= 156) were enrolled
from May 2016 to April 2017 after written informed consent. Inclusion criteria for patients with …

[HTML][HTML] Serum lactate dehydrogenase isoenzymes 4 plus 5 is a better biomarker than total lactate dehydrogenase for refractory Mycoplasma pneumoniae pneumonia …

TY Liu, WJ Lee, CM Tsai, KC Kuo, CH Lee… - Pediatrics & …, 2018 - Elsevier
Although usually self-limiting, Mycoplasma pneumoniae pneumonia (MPP) may lead to
clinical or radiological deterioration despite macrolide antibiotic therapy, resulting in the …